Termination of pregnancy for foetal indication in the French context analysis of decision-making in a Multidisciplinary Centre For Prenatal Diagnosis

Stoll, 2001, Detection of congenital anomalies by fetal ultrasonographic examination across Europe, Community Genet, 4, 25 Garne, 2010, EUROCAT website data on prenatal detection rates of congenital anomalies, J Med Screen, 17, 97, 10.1258/jms.2010.010050 Garne, 2010, Termination of pregnancy for fetal anomaly after 23 weeks of gestation: a European register-based study, BJOG, 117, 660, 10.1111/j.1471-0528.2010.02531.x Mansfield, 1999, Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly and turner and Klinefelter syndromes: a systematic literature review, Prenat Diagn, 19, 808, 10.1002/(SICI)1097-0223(199909)19:9<808::AID-PD637>3.0.CO;2-B Garel, 2002, Ethical decision-making in prenatal diagnosis and termination of pregnancy: a qualitative survey among physicians and midwives, Prenat Diagn, 22, 10.1002/pd.427 Registry Prenatal Screening Policies in Europe, 2010 French law no. 45-17 January 17, 2001. https://www.legifrance.gouv.fr /affichTexte.do?cidTexte=JORFTEXT000000700230 (accessed dec, 2017). French Public Health Code/Code de la Santé Publique. Art L.2213-1 https://www.legifrance.gouv.fr/affichCodeArticle.do?cidTexte=LEGITEXT000006072665&idArticle=LEGIARTI000006687544&dateTexte=&categorieLien=cid ((accessed dec, 2017). French Public Health Code/Code de la Santé publique. Art R.2131-10 https://www.legifrance.gouv.fr/affichCodeArticle.do?cidTexte=LEGITEXT000006072665&idArticle=LEGIARTI000006911250&dateTexte=& categorieLien=cid (accessed dec, 2017). French law, Decree June 2015. https://www.legifrance.gouv.fr/eli/arrete/2015/6/1/ AFSP1512973A/jo/texte. French Biomedical Agency. Le rapport médical et scientifique de l’Agence de la biomédecine. 2015; https://www.agence-biomedecine.fr/annexes/bilan2016/donnees/diag-prena/02-centres/synthese.htm#tCPDPN1. Dommergues, 2010, Termination of pregnancy following prenatal diagnosis in France: how severe are the foetal anomalies?, Prenat Diagn, 30, 531, 10.1002/pd.2510 Ukuhor, 2017, A framework for describing the influence of service organisation and delivery on participation in fetal anomaly screening in England, J Pregnancy, 2017, 13, 10.1155/2017/4975091 Gruchy, 2016, Pregnancy outcomes in prenatally diagnosed 47, XXX and 47, XYY syndromes: a 30-year French, retrospective, multicentre study, Prenat Diagn, 36, 523, 10.1002/pd.4817 Statham, 2006, Late termination of pregnancy: law, policy and decision making in four English fetal medicine units, BJOG, 113, 1402, 10.1111/j.1471-0528.2006.01144.x Hemminki, 2000, Views of Finnish doctors on fetal screening, BJOG, 107, 656, 10.1111/j.1471-0528.2000.tb13309.x Savulescu, 2001, Is current practice around late termination of pregnancy eugenic and discriminatory? Maternal interests and abortion, J Med Ethics, 27, 165, 10.1136/jme.27.3.165 De Vigan, 2002, Mothers’ knowledge of screening for trisomy 21 in 1999: a survey in Paris maternity units, Eur J Obstet Gynecol Reprod Biol, 104, 14, 10.1016/S0301-2115(01)00559-0 Aksoy, 2001, Antenatal screening and its possible meaning from unborn baby’s perspective, BMC Med Ethics, 2, 3, 10.1186/1472-6939-2-3 Clancy, 2010, A clinical perspective on ethical arguments around prenatal diagnosis and preimplantation genetic diagnosis for later onset inherited cancer predispositions, Fam Cancer, 9, 9, 10.1007/s10689-009-9271-7 French Biomedical Agency/Agence de la Biomédecine, 2012 J. Leborne. L’embryon et le fœtus, entre personne et chose, entre science et droit : des protections d’intérêts : Revue générale du droit on line, 2020, numéro 51180). http://www.assemblee-nationale.fr/dyn/15/textes/l15t0474_texte-adopte-seance.pdf. Lewis, 2013, Non-invasive prenatal testing for Down’s syndrome: pregnant women’s views and likely uptake, Public Health Genomics, 16, 223, 10.1159/000353523 Hill, 2016, Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionalswomen and health professionals, Eur J Hum Genet, 24, 964, 10.1038/ejhg.2015.249 Metcalfe, 2014, Beyond trisomy 21: additional chromosomal anomalies detected through RoutineAneuploidy screening, J Clin Med, 3, 388, 10.3390/jcm3020388 Munthe, 2015, A new ethical landscape of prenatal testing: individualizing choice to serve and promote public health: a radical proposal, Bioethics, 29, 36, 10.1111/bioe.12126 Asplin, 2014, Pregnancy termination due to fetal anomaly: women’s reactions, satisfaction and experiences of care, Midwifery, 20, 620, 10.1016/j.midw.2013.10.013 Martin, 2018, Introduction of non-invasive prenatal testing as a first-tier aneuploidy screening test: a survey among Dutch midwives about their role as counsellors, Midwifery, 56, 1, 10.1016/j.midw.2017.09.008 Rebouché, 2015, Non-Invasive Testing, Non-Invasive Counseling, J Law Med Ethics, 43, 228, 10.1111/jlme.12237 Richardson, 2017, Ethical considerations in prenatal testing: genomic testing and medical uncertainty, Semin Fetal Neonatal Med De Jong, 2015, Prenatal screening: current practice, new developments, ethical challenges, Bioethics, 29, 1, 10.1111/bioe.12123